VBL Therapeutics Announces Year Ended December 31, 2018 Financial Results and Provides Corporate Update

NEXT STORY
Oxford Immunotec Announces New Initiative to Bring the Benefit of Modern Tuberculosis Testing to the Russian Federation
PREV STORY
Athenex Announces Appointment of Dr. Daniel Von Hoff as Chairman of the Scientific Advisory Board of Axis Therapeutics Limited
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Melinta Therapeutics Announces Preliminary Second Quarter 2019 Financial Results and Provides Corporate Update

author_avatar
NASDAQ Market News

Predictive Oncology’s, Skyline Medical Division, Developing Generation 3 Direct-to-Drain Automated Fluid Waste Management System

author_avatar
NASDAQ Market News

Statement Re: Appointment to NHS GP IT Futures

author_avatar
NASDAQ Market News